文献速递胸部肿瘤

肺癌计算机断层扫描筛查的现状与未来展望:国际肺癌研究协会2023至2027年路线图

Current and Future Perspectives on Computed Tomography Screening for Lung Cancer: A Roadmap From 2023 to 2027 From the International Association for the Study of Lung Cancer.
PubMed 文献 · J Thorac Oncol · 2023-07-23

本综述基于国际肺癌研究协会第九届CT筛查研讨会,聚焦低剂量CT筛查肺癌全球实施的主要主题,并制定全球推广策略。建议提供五年路线图,涵盖建立通用筛查质量指标、制定从不吸烟高危人群的循证标准、规范偶发肺结节追踪、整合人工智能与生物标志物、标准化AI性能协议、基于个体风险个性化筛查间隔、评估其他异常的成本效益、开发地理空间工具监测公平可及性、建立全球共享教育资源等九项内容。

要点

  • 低剂量CT筛查可显著降低肺癌死亡率,随机对照试验和Meta分析已证实。
  • 建议建立通用筛查质量指标和从不吸烟高危人群的循证标准。
  • 建议整合人工智能与生物标志物,并标准化高质量AI性能协议。

核心结论

  • 低剂量CT筛查可显著降低肺癌死亡率,本综述提出2023至2027年全球实施路线图。

研究设计与样本

  • 本综述基于国际肺癌研究协会第九届CT筛查研讨会,聚焦低剂量CT筛查全球实施的主要主题。

主要发现

  • 随机对照试验和Meta分析显示低剂量CT筛查可显著降低肺癌死亡率。

关键数值与推荐

  • 建议建立通用筛查项目质量指标。
  • 建议建立循证标准以识别从不吸烟但肺癌高危个体。
  • 建议制定偶发肺结节追踪和管理方案以补充项目性肺癌筛查。
  • 建议整合人工智能和生物标志物以提高可疑CT筛查病灶的恶性预测。
  • 建议标准化高质量人工智能性能协议以大幅降低成本和资源利用及放射科医生报告时间。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Low-dose computed tomography (LDCT) screening for lung cancer substantially reduces mortality from lung cancer, as revealed in randomized controlled trials and meta-analyses. This review is based on the ninth CT screening symposium of the International Association for the Study of Lung Cancer, which focuses on the major themes pertinent to the successful global implementation of LDCT screening and develops a strategy to further the implementation of lung cancer screening globally. These recommendations provide a 5-year roadmap to advance the implementation of LDCT screening globally, including the following: (1) establish universal screening program quality indicators; (2) establish evidence-based criteria to identify individuals who have never smoked but are at high-risk of developing lung cancer; (3) develop recommendations for incidentally detected lung nodule tracking and management protocols to complement programmatic lung cancer screening; (4) Integrate artificial intelligence and biomarkers to increase the prediction of malignancy in suspicious CT screen-detected lesions; and (5) standardize high-quality performance artificial intelligence protocols that lead to substantial reductions in costs, resource utilization and radiologist reporting time; (6) personalize CT screening intervals on the basis of an individual's lung cancer risk; (7) develop evidence to support clinical management and cost-effectiveness of other identified abnormalities on a lung cancer screening CT; (8) develop publicly accessible, easy-to-use geospatial tools to plan and monitor equitable access to screening services; and (9) establish a global shared education resource for lung cancer screening CT to ensure high-quality reading and reporting.

来源:J Thorac Oncol,查看原文。版权归原作者所有。

引用

  1. Lam S, Bai C, Baldwin DR, et al. Current and Future Perspectives on Computed Tomography Screening for Lung Cancer: A Roadmap From 2023 to 2027 From the International Association for the Study of Lung Cancer. J Thorac Oncol. 2023. PMID: 37487906. doi:10.1016/j.jtho.2023.07.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。